Results 291 to 300 of about 17,175,483 (375)

Generating MRI‐Derived CSF Proxy‐Markers to Predict and Visualize Alzheimer's Disease Progression

Human Brain Mapping, Volume 46, Issue 16, November 2025.
Deep learning models trained on structural MRI to predict cerebrospinal fluid‐based amyloid and tau concentrations can generate latent representations (MRI‐derived CSF proxy/surrogate markers) that can be subsequently transferred for Alzheimer's disease detection and risk prediction, bypassing noninvasive testing and enabling regional distribution ...
Anees Abrol, Vince D. Calhoun, for the Alzheimer's Disease Neuroimaging Initiative   +2 more
wiley   +1 more source

Validation of a renal staging system and its association with renal amyloid deposition burden in AL amyloidosis. [PDF]

Ren Fail
Yao Y, Wang S, Li DY, Yu XJ, Liu JY, Qiu ZX, Zhou FD, Wang SX.   +7 more
europepmc   +1 more source

The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista, Diego Martinelli, Marco Spada, Carlo Dionisi‐Vici   +3 more
wiley   +1 more source

A CASE OF (AL) AMYLOIDOSIS THAT OCCURRED MULTIPLE INTESTINAL PERFORATION DURING PACLITAXEL CHEMOTHERAPY

, 2010
Tsuyoshi Fukushima, Hidekazu Sano, Kazutomo KIKUCHI, Masataka Wada, Yumi Okawa, Keisa Takeda   +5 more
openalex   +2 more sources

Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.)

, 2012

openalex   +2 more sources

Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis. [PDF]

Blood Neoplasia
Yohannan B, Rees M, Gertz MA, Dispenzieri A, Kapoor P, Buadi FK, Dingli D, Leung N, Lacy MQ, Hayman SR, Gonsalves W, Kourelis T, Cook J, Binder M, Siddiqui M, Lin Y, Hwa L, Rogers MG, Hobbs M, Fonder A, Warsame R, Rajkumar SV, Kumar SK, Muchtar E.   +23 more
europepmc   +1 more source

Aryl Hydrocarbon Receptor in Health and Disease

MedComm, Volume 6, Issue 11, November 2025.
Based on the structure and ligands of AhR, this review introduces the AhR‐related signaling pathways and their roles in health and diseases. Agonists and antagonists of AhR as well as new strategies for treatment using the microbial–AhR axis are summarized. A prospect was made for the future use of AhR as a therapeutic target.
Haonan Li, Yufeng Fan, Jizheng Liu, Shumin Dong, Bin Wen, Yunfei Zhang, Xiaocui Wang, Xuemei Duan, Ying Hu, Ze Yan, Huifeng Shang, Yukai Jing   +11 more
wiley   +1 more source

A Rare Lung Nodule Consisting of Adenocarcinoma and Amyloid Deposition in a Patient with Primary Systemic AL Amyloidosis

, 2011
Daigo Miyazaki, Masahide Yazaki, Wataru Ishii, Masayuki Matsuda, Yoshinobu Hoshii, Kenji Nara, Jun Nakayama, Shu‐ichi Ikeda   +7 more
openalex   +2 more sources

Amyloid Light-Chain (AL) Amyloidosis in a Middle-Aged Lady: Confronting the Challenges of a Rare Diagnosis in a Developing Country. [PDF]

Cureus
Piyarathna C, Samaraweera Y, Ranasinghe N, Piyasundara L, Mujahieth MI.   +4 more
europepmc   +1 more source

AL amyloidosis: from molecular mechanisms to targeted therapies.

Hematology. American Society of Hematology. Education Program, 2017
G. Merlini
semanticscholar   +1 more source